BSECompany Update9h ago · 20 Oct 2026, 04:12 pm

Disclosure under Regulation 30 and Regulation 30A of the SEBI (LODR) Regulations, 2015 regarding Mr. Yogesh Agrawal (hereinafter referred to as the "Promoters" or "Promoter Sellers") of the Company has entered into Share Purchase Agreement ("SPA") with Mr. Pankaj Grover and Mr. Abhisek Gupta (hereinafter referred to as "Acquirers") pursuant to which the promoters sellers propose to sell entire of their shareholding in the company to the acquirers.

Genomic Valley Biotech Ltd · 539206

✦ AI Summary▼ NegativeM&A

Genomic Valley Biotech Ltd's promoter, Yogesh Agrawal, has entered into a Share Purchase Agreement with Pankaj Grover and Abhisek Gupta to sell their entire shareholding in the company. The transaction will result in the acquirers acquiring control over the company and will attract an obligation to make an open offer to public shareholders.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern8/10
Regulatory Risk9/10
Balance Sheet Risk6/10
Liquidity Impact4/10
Market Sentiment2/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Genomic Valley Biotech Ltd - 539206 - Disclosure Under Regulation 30 And Regulation 30A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI (LODR) Regulations')

Attachments (1)

📄

19b78ec6-fe8d-4098-b7f0-0d034c580bd2.pdf

pdf

Download →
View document text
Date: October 19, 2026 Listing Department BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai- 400001 Dear Sir/Madam, Sub: Disclosure under Regulation 30 and Regulation 30A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“SEBI (LODR) Regulations”) This is to inform that Mr. Yogesh Agrawal, (hereinafter referred to as the “Promoters” or “Promoter Sellers”) of Genomic Valley Biotech Limited (hereinafter referred to as “Company”) has entered into a Share Purchase Agreement (“SPA”) dated October 19, 2026 with Mr. Pankaj Grover and Mr. Abhisek Gupta (hereinafter referred to as “Acquirers”) pursuant to which the promoter sellers propose to sell entire of their shareholding in the Company to the Acquirers. The consummation of the SPA would result in the Acquirers acquiring control over the Company. The above said transaction shall attract an obligation on the Acquirers to make an Open Offer to the public shareholders of the Company in terms of applicable regulation of Securities and Exchange Board of India (Substantial Acquisitions of Shares and Takeovers) Regulation, 2011 (“SEBI (SAST) Regulations). Please find attached Annexure I to this letter, disclosed pursuant to Regulation 30 and 30A of SEBI (LODR) Regulations and as per the master circular bearing reference number HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026. Kindly take the same on record. Yours faithfully, For Genomic Valley Biotech Limited Yogesh Agrawal Managing Director DIN: 01165288 Annexure - I S. Particulars a If the listed entity is a party to the Not applicable agreement, i. Details of the counterparties (including name and relationship with the listed entity) b. If listed entity is not a party to the agreement, S. Name of the Relationship i. Name of the party entering No. party with the into such an agreement and Company the relationship with the 1. Yogesh Agrawal Promoter Seller listed entity; ii. Details of the counterparties to the agreement (including S. Name of the Relationship name and relationship with No. party with the the listed entity); Company 1. Pankaj Grover Acquirer 2. Abhisek Gupta Acquirer iii. Date of entering into the The Share Purchase Agreement has been agreement executed on October 19, 2026. c. Purpose of entering into the The Promoter Sellers and the Acquirers have agreement executed a Share Purchase Agreement whereby the Acquirers proposes to acquire 14,07,000 (Fourteen Lakhs Seven Thousand) Equity Shares, representing 46.06% (Forty Six Point Zero Six Percent) of the Voting Share Capital of the Company in the manner and terms of the SPA. Further, the proposed transaction shall attract an obligation on the Acquirers to make an open offer as required under SEBI (SAST) Regulations. d. Shareholding, if any, in the Shareholding of the Promoter Sellers prior to SPA: entity with whom the S. Name No. of shares % of agreement is executed No. holdings 1. Yogesh 14,07,000 46.06% Agrawal Shareholding of the Acquirers prior to SPA: S. Particulars No. of % of No. shares holdings 1. Pankaj Grover Nil Nil 2. Abhisek Gupta Nil Nil e. Significant terms of the In terms of the SPA, the Acquirers have agreed to purchase agreement (in brief) from the Promoter Sellers and the Promoter Sellers have agreed to sell the Acquirers 14,07,000 Equity Shares of Rs. 10/- each being 46.06% of the total voting share capital of the Company in the manner and subject to the terms and conditions contained herein. f. Extent and the nature of Pursuant to the completion of Open Offer and the impact on management or consummation of the Proposed Transaction and subject to control of the listed entity compliance with the SEBI (SAST) Regulations, the Acquirers will acquire and exercise control over the Target Company and will be classified as Promoters of the Target Company in accordance with the provisions of Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. g. Details and quantification of Not applicable the restriction or liability imposed upon the listed entity h. Whether the said parties are Except promoter seller, none of the parties to the SPA is related to related to promoter/promoter group/group companies in promoter/promoter any manner. group/group companies in any manner. If yes, nature of relationship i. Whether the T h e t r a n s a c t i o n e x e c u t e d a s per Share Purchase transaction would fall within Agreement would not be considered as a related party transactions? If yes, related party transaction. whether the same is done at “arm’s length” j. In case of issuance of shares to the Not applicable parties, details of issue price, class of shares issued; k. Any other disclosures related to Upon completion of proposed transaction, the such agreements, viz., details of existing promoter directors shall tender their nominee on the board of directors of resignation from the board of the Company. the listed entity, potential conflict of interest arising out of such agreements, etc. l. In case of rescission, amendment or Not applicable alteration, listed entity shall disclose additional details to the stock exchange(s): i. name of parties to the agreement - ii. nature of the agreement; - iii. date of execution of the - agreement; iv. details and reasons for - amendment or alteration and impact thereof (including impact on management or control and on the restriction or liability quantified earlier) v. reasons for rescission and - impact thereof (including impact on management or control and on the restriction or liability quantified earlier).